LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 962 | 400 | 10692 | 0.0375 | -0.2234 |
MCF 10A | AZD7762 | 10 | uM | LJP6 | 72 | hr | 962 | 414 | 10692 | 0.0388 | -0.2181 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 658 | 154 | 3933 | 0.0392 | -0.4301 |
MCF 10A | PF431396 | 10 | uM | LJP5 | 72 | hr | 962 | 413 | 10512 | 0.0392 | -0.2201 |
Hs 578T | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 658 | 147 | 3761 | 0.0393 | -0.4481 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP5 | 72 | hr | 1235 | 185 | 4660 | 0.0399 | -0.6288 |
BT-20 | Mitoxantrone | 10 | uM | LJP5 | 72 | hr | 1097 | 158 | 3846 | 0.0411 | -0.6586 |
MCF7 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1209 | 170 | 4012 | 0.0422 | -0.6806 |
MCF 10A | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 962 | 452 | 10692 | 0.0423 | -0.1955 |
MCF 10A | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 962 | 460 | 10692 | 0.0431 | -0.1920 |
MCF 10A | JNK-9L | 3.33 | uM | LJP6 | 72 | hr | 962 | 460 | 10692 | 0.0431 | -0.1928 |
MCF 10A | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 962 | 480 | 10512 | 0.0457 | -0.1828 |
MCF 10A | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 962 | 491 | 10692 | 0.0460 | -0.1764 |
Hs 578T | LDN-193189 | 3.33 | uM | LJP5 | 72 | hr | 658 | 183 | 3933 | 0.0465 | -0.3919 |
MDA-MB-231 | Mitoxantrone | 3.33 | uM | LJP6 | 72 | hr | 1235 | 205 | 4405 | 0.0467 | -0.6246 |
Hs 578T | WH-4-025 | 10 | uM | LJP5 | 72 | hr | 658 | 186 | 3933 | 0.0473 | -0.3913 |
MCF 10A | Radicicol | 10 | uM | LJP5 | 72 | hr | 962 | 495 | 10512 | 0.0473 | -0.1775 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 72 | hr | 962 | 514 | 10692 | 0.0481 | -0.1662 |
MCF 10A | Mitoxantrone | 10 | uM | LJP5 | 72 | hr | 962 | 509 | 10512 | 0.0484 | -0.1687 |
MCF 10A | QL-XII-47 | 10 | uM | LJP6 | 72 | hr | 962 | 522 | 10692 | 0.0488 | -0.1619 |
Hs 578T | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 658 | 184 | 3761 | 0.0492 | -0.3976 |
MCF 10A | WZ3105 | 0.37 | uM | LJP5 | 72 | hr | 962 | 522 | 10512 | 0.0498 | -0.1629 |
MCF 10A | Mitoxantrone | 10 | uM | LJP6 | 72 | hr | 962 | 552 | 10692 | 0.0517 | -0.1484 |
MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 72 | hr | 1235 | 234 | 4405 | 0.0524 | -0.6111 |
MCF 10A | Withaferin A | 10 | uM | LJP6 | 72 | hr | 962 | 574 | 10692 | 0.0537 | -0.1393 |